Physician profile

Edna Pleasant

Physician Assistant · Bayshore, NY

NPI 1457578056

$5,521.14

in general payments reported to CMS, 2019-2025

39 companies · $1,067 in 2025

The $1,067 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).

See the full distribution for Physician Assistant

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,836.62
Education$65.99

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Bayer Healthcare Pharmaceuticals INC. $1,510.12 2021-2025
Novo Nordisk INC $403.55 2022-2025 Ozempic, Rybelsus, Wegovy
Intuity Medical INC $340.78 2022-2023 Pogo Automatic Blood Glucose Monitoring System
Abbvie INC. $319.51 2022-2025
Takeda Pharmaceuticals U.S.A., INC. $266.40 2023-2025 Glassia, Aralast
Boston Scientific Corporation $187.50 2021-2023
Astellas Pharma US INC $185.93 2023-2025 Veozah
Novartis Pharmaceuticals Corporation $171.47 2024-2025
Glaxosmithkline, LLC. $169.75 2021-2023 Trelegy Ellipta
Lilly USA, LLC $163.02 2021-2025 Jardiance, Mounjaro
Sumitomo Pharma America, INC. $160.85 2024 Gemtesa
Merck Sharp & Dohme LLC $152.36 2021-2025 Capvaxive, Gardasil 9, Gardasil
Pfizer INC. $148.48 2021-2025
Abbott Laboratories $144.24 2021-2025 Cardiomems, Freestyle Libre 3
Exact Sciences Corporation $129.15 2023-2025 Cologuard Collection Kit
Show all 39 companies
CompanyGeneral paymentsYearsTop products
Sanofi-Aventis U.S. LLC $113.79 2021-2024
Esperion Therapeutics, INC. $107.62 2021-2025 Nexletol
Amgen INC. $96.67 2021-2023 Repatha, Otezla
Boehringer Ingelheim Pharmaceuticals, INC. $89.89 2021-2022
Daiichi Sankyo INC. $74.29 2022-2023 Injectafer
Amarin Pharma, INC. $62.21 2021
Idorsia Pharmaceuticals US INC $59.74 2023 Quviviq
Astrazeneca Pharmaceuticals LP $59.21 2021-2022
Horizon Therapeutics Plc $51.03 2021-2022
Paratek Pharmaceuticals, INC. $40.73 2021
Genentech USA, INC. $35.38 2021
Corcept Therapeutics $33.82 2023 Korlym
Biohaven Pharmaceutical Holding Company LTD. $29.10 2022
Sanofi Pasteur INC. $24.35 2023
Regeneron Healthcare Solutions, INC. $23.82 2025 Dupixent
Intra-Sana Laboratories $22.26 2024 Glycate, Reltone 200 Mg, Reltone 400 Mg
Shield Therapeutics INC $20.98 2024
Avvisto Therapeutics, LLC $20.61 2025 Cycloset
Hikma Pharmaceuticals USA $20.54 2023 Ryaltris
Nabriva Therapeutics, Plc $18.00 2021
Vivus LLC $17.78 2021
Seqirus USA INC $16.67 2022
Janssen Pharmaceuticals, INC $14.90 2021
Dexcom, INC. $14.64 2025 Dexcom G6 Transmitter

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Edna Pleasant

$5,521.14

in general payments reported 2019-2025

Years
2021-2025
Top company
Bayer Healthcare Pharmaceuticals INC.
Context
The $1,067 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).

https://glasscript.com/doctor/10681465/edna-pleasant

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.